Read More Healthcare Industry News Why Hims & Hers Health’s new COO appointment matters as FDA scrutiny and growth collide Hims & Hers Health (NASDAQ: HIMS) promotes Mike Chi to COO, consolidating leadership as it faces growth, regulation, and investor scrutiny in telehealth. byPallavi MadhirajuOctober 3, 2025